QSS
HRTX icon

Quantitative Systematic Strategies’s Heron Therapeutics HRTX Stock Holding History

Quantitative Systematic Strategies’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,137
Closed -$680K – 677
2020
Q4 		$680K Buy
+32,137
New +$559K 0.1% 325
2020
Q2 		– Sell
-11,866
Closed -$139K – 590
2020
Q1 		$139K Buy
+11,866
New +$223K 0.11% 218
2016
Q1 		– Sell
-10,854
Closed -$303K – 575
2015
Q4 		$303K Buy
+10,854
New +$290K 0.08% 591

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Quantitative Systematic Strategies's HRTX Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Heron Therapeutics (HRTX) in Q1 2021, closing a stake of 32,137 shares — an estimated $680K sold.

Quantitative Systematic Strategies first reported a position in HRTX in Q4 2015 and held it in 3 quarters. The position peaked at $680K in Q4 2020. 193 funds tracked by Wall St. Rank hold HRTX as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Heron Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 32,137 Heron Therapeutics shares in Q1 2021, an estimated $680K.
  • Quantitative Systematic Strategies first reported a position in Heron Therapeutics in Q4 2015 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Heron Therapeutics position peaked at $680K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.